The fact is that not all MPN patients possess Jak2 mutations and only minor proportion of MPN patients carries MPL mutations, indicating that the diagnostic value of Jak2 or MPL mutations is limited by suboptimal sensitivity and specificity. Here, MPL is linked to myeloproliferative neoplasm.